RELATED ARTICLES |
“This has been a good quarter for Dabur with all-round improvement. We sustained good growth momentum across key consumer care categories and geographies," Dabur India chief executive Sunil Duggal said in a statement on Wednesday. The recently-acquired Fem skin care business recorded a 25.5 per cent jump during the period. The foods business also posted a strong 21.4 per cent growth. The digestives & baby care category reported a 12.4 per cent growth, while the health supplements business — riding on strong demand for its flagship product Dabur Chyawanprash — ended the quarter with an over 10 per cent growth.
Recently, in an exclusive interview with Financial Chronicle, Amit Burman, the vice chairman at Dabur said, “In next four to five years, the OTC segment will be between Rs 2,000 to Rs 2,500 crores in terms of revenue. We will also be adding new products. If you look at OTC, it is already ahead of food. If we do it correctly, OTC, food and skin care should be at par with each other.”


















Post new comment